CWG
ISEE

C WorldWide Group’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

C WorldWide Group’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-53,000
Closed -$256K – 136
2016
Q4 		$256K Hold
53,000
– – ﹤0.01% 113
2016
Q3 		$2.44M Buy
+53,000
New +$2.99M 0.04% 83

Other funds holding ISEE

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
BIM
Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

C WorldWide Group's ISEE Position: Q1 2017 in Review

C WorldWide Group sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q1 2017, closing a stake of 53,000 shares — an estimated $256K sold.

C WorldWide Group first reported a position in ISEE in Q3 2016 and held it in 2 quarters. The position peaked at $2.44M in Q3 2016. 100 funds tracked by Wall St. Rank hold ISEE as of Q1 2017.

  • C WorldWide Group reported no remaining IVERIC bio, Inc. Common Stock position as of Q1 2017 after selling out during the quarter.
  • C WorldWide Group sold 53,000 IVERIC bio, Inc. Common Stock shares in Q1 2017, an estimated $256K.
  • C WorldWide Group first reported a position in IVERIC bio, Inc. Common Stock in Q3 2016 and held it in 2 quarters.
  • C WorldWide Group's IVERIC bio, Inc. Common Stock position peaked at $2.44M in Q3 2016.
  • 100 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q1 2017.

Based on C WorldWide Group's 13F filing for Q1 2017, filed 1 May 2017.